English Polski
Tom 16, Nr 3 (2021)
Opis przypadku
Opublikowany online: 2021-06-30

dostęp otwarty

Wyświetlenia strony 462
Wyświetlenia/pobrania artykułu 368
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Migotanie przedsionków czy przetrwały otwór owalny — gdzie leży przyczyna nawracających udarów niedokrwiennych mózgu?

Karolina Bula1, Tomasz Bochenek1, Marek Grabka1, Katarzyna Mizia-Stec1
Folia Cardiologica 2021;16(3):177-179.

Streszczenie

Ischemic stroke is one of the major causes of death and disability in high-developed countries. Closure of PFO is recommended if other causes of ischemic stroke, like atrial fibrillation, were excluded, especially in young patients. We present a case report of a 75-years-old female patient with five ischemic strokes in her medical history and newly diagnosed patent foramen ovale. Atrial fibrillation was detected 25 years after first ischemic event. Implementation of anticoagulation therapy has prevented new ischemic strokes in our patient. According to emerging meta-analyses such treatment is sufficient not only in AF, but also in PFO related ischemic strokes. The patient had another risk factors for paradoxical embolism such as varices, post-thrombotic syndrome of lower limbs and the Eustachian valve, so it is unclear whether AF has been the major cause of all ischemic stroke in present case. Significant bleeding from limb varices during anticoagulation treatment occurred and required urgent surgical intervention. Because of the high risk of recurrent haemorrhages (HAS-BLED Score – 4 points), the patient was considered to two percutaneous procedures: occlusion of the left atrial appendage (LAA) and consecutively second - PFO closure as additional prevention of stroke. This is an illustrative case that opens discussion on necessity and timing of cardiac interventions once possible cardiac sources of ischemic strokes are found and new facts arise.

Artykuł dostępny w formacie PDF

Pokaż PDF (angielski) Pobierz plik PDF

Referencje

  1. Feigin VL, Mensah GA, Norrving Bo, et al. GBD 2013 Stroke Panel Experts Group. Atlas of the global burden of stroke (1990–2013): the GBD 2013 study. Neuroepidemiology. 2015; 45(3): 230–236.
  2. Pistoia F, Sacco S, Tiseo C, et al. The epidemiology of atrial fibrillation and stroke. Cardiol Clin. 2016; 34(2): 255–268.
  3. Pristipino C, Sievert H, D’Ascenzo F, et al. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism. Eur Heart J. 2018; 40(38): 3182–3195.
  4. Kent DM, Ruthazer R, Weimar C, et al. An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke. Neurology. 2013; 81(7): 619–625.
  5. Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021; 42(5): 373–498.
  6. Mir H, Siemieniuk RA, Ge L, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline. BMJ. 2018; 362(7): k2515.
  7. Anantha-Narayanan M, Anugula D, Das G. Patent foramen ovale closure reduces recurrent stroke risk in cryptogenic stroke: a systematic review and meta-analysis of randomized controlled trials. World J Cardiol. 2018; 10(6): 41–48.
  8. Turc G, Calvet D, Guérin P, et al. CLOSE Investigators. AClosure, anticoagulation, or antiplatelet therapy for cryptogenic stroke with patent foramen ovale: systematic review of randomized trials, sequential meta-analysis, and new insights from the CLOSE study. J Am Heart Assoc. 2018; 7(12).
  9. Casu G, Gulizia MM, Molon G, et al. ANMCO/AIAC/SICI-GISE/SIC/SICCH Consensus Document: percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation patients: indications, patient selection, staff skills, organisation, and training. Eur Heart J Suppl. 2017; 19(Suppl D): D333–D353.